STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1
BRCA1, a multi-domain protein, is mutated in a large percentage of hereditary breast and ovarian cancers. BRCA1 is most often mutated in three domains or regions: the N-terminal RING domain, exons 11–13, and the BRCT domain. The BRCA1 RING domain is responsible for the E3 ubiquitin ligase activity o...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2012-04-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037014601070 |
_version_ | 1828849138643501056 |
---|---|
author | Serena L. Clark Ana M. Rodriguez Russell R. Snyder Gary D.V. Hankins Darren Boehning |
author_facet | Serena L. Clark Ana M. Rodriguez Russell R. Snyder Gary D.V. Hankins Darren Boehning |
author_sort | Serena L. Clark |
collection | DOAJ |
description | BRCA1, a multi-domain protein, is mutated in a large percentage of hereditary breast and ovarian cancers. BRCA1 is most often mutated in three domains or regions: the N-terminal RING domain, exons 11–13, and the BRCT domain. The BRCA1 RING domain is responsible for the E3 ubiquitin ligase activity of BRCA1 and mediates interactions between BRCA1 and other proteins. BRCA1 ubiquitinates several proteins with various functions. The BRCA1 BRCT domain binds to phosphoproteins with specific sequences recognized by both BRCA1 and ATM/ATR kinases. Structural studies of the RING and BRCT domains have revealed the molecular basis by which cancer causing mutations impact the functions of BRCA1. While no structural data is available for the amino acids encoded by exons 11–13, multiple binding sites and functional domains exist in this region. Many mutations in exons 11–13 have deleterious effects on the function of these domains. In this mini-review, we examine the structure-function relationships of the BRCA1 protein and the relevance to cancer progression. |
first_indexed | 2024-12-12T22:45:42Z |
format | Article |
id | doaj.art-aa36e5c73f5f4efcac4069d50f9aa04f |
institution | Directory Open Access Journal |
issn | 2001-0370 |
language | English |
last_indexed | 2024-12-12T22:45:42Z |
publishDate | 2012-04-01 |
publisher | Elsevier |
record_format | Article |
series | Computational and Structural Biotechnology Journal |
spelling | doaj.art-aa36e5c73f5f4efcac4069d50f9aa04f2022-12-22T00:09:13ZengElsevierComputational and Structural Biotechnology Journal2001-03702012-04-011110.5936/csbj.201204005STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1Serena L. Clark0Ana M. Rodriguez1Russell R. Snyder2Gary D.V. Hankins3Darren Boehning4Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, 77550Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, 77550Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, 77550Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX, 77550Department of Neuroscience and Cell Biology, University of Texas Medical Branch, Galveston, TX, 77550BRCA1, a multi-domain protein, is mutated in a large percentage of hereditary breast and ovarian cancers. BRCA1 is most often mutated in three domains or regions: the N-terminal RING domain, exons 11–13, and the BRCT domain. The BRCA1 RING domain is responsible for the E3 ubiquitin ligase activity of BRCA1 and mediates interactions between BRCA1 and other proteins. BRCA1 ubiquitinates several proteins with various functions. The BRCA1 BRCT domain binds to phosphoproteins with specific sequences recognized by both BRCA1 and ATM/ATR kinases. Structural studies of the RING and BRCT domains have revealed the molecular basis by which cancer causing mutations impact the functions of BRCA1. While no structural data is available for the amino acids encoded by exons 11–13, multiple binding sites and functional domains exist in this region. Many mutations in exons 11–13 have deleterious effects on the function of these domains. In this mini-review, we examine the structure-function relationships of the BRCA1 protein and the relevance to cancer progression.http://www.sciencedirect.com/science/article/pii/S2001037014601070ApoptosisBcl-2BaxBH3 domainApaf-1Apoptosome |
spellingShingle | Serena L. Clark Ana M. Rodriguez Russell R. Snyder Gary D.V. Hankins Darren Boehning STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1 Computational and Structural Biotechnology Journal Apoptosis Bcl-2 Bax BH3 domain Apaf-1 Apoptosome |
title | STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1 |
title_full | STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1 |
title_fullStr | STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1 |
title_full_unstemmed | STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1 |
title_short | STRUCTURE-FUNCTION OF THE TUMOR SUPPRESSOR BRCA1 |
title_sort | structure function of the tumor suppressor brca1 |
topic | Apoptosis Bcl-2 Bax BH3 domain Apaf-1 Apoptosome |
url | http://www.sciencedirect.com/science/article/pii/S2001037014601070 |
work_keys_str_mv | AT serenalclark structurefunctionofthetumorsuppressorbrca1 AT anamrodriguez structurefunctionofthetumorsuppressorbrca1 AT russellrsnyder structurefunctionofthetumorsuppressorbrca1 AT garydvhankins structurefunctionofthetumorsuppressorbrca1 AT darrenboehning structurefunctionofthetumorsuppressorbrca1 |